Al-Tabba' Amal, Dajani Rana, Al-Hussaini Maysa
Office of Human Research Protection Program, King Hussein Cancer Center, Amman, Jordan.
Department of Biology and Biotechnology, Hashemite University, Zarqa, Jordan.
Front Genet. 2020 Jul 17;11:657. doi: 10.3389/fgene.2020.00657. eCollection 2020.
The use of stem cells in research has caused much controversy and ethical dilemma. The primary source of stem cells is human embryos, a source which has been confronted with objections based on ethical, moral, and religious positions. Jordan has passed the first of its-kind Statute in the region, aiming at regulating the use of stem cells both for therapeutic and research purposes. The Statute adopted a regulatory approach between the restrictive and intermediate. The Statute, however, pays more attention to stem cell banking in many of its articles. Many critical aspects in regulating stem cell research activities are overlooked. This is including but not limited to the process of informed consent, protecting privacy, maintaining confidentiality, the need for a national entity responsible for regulating embryonic stem cell (ESC) research, and requirements of monitoring activity. The authors recommend further review of the current Statute in light of the deficiencies discussed so as to develop a more comprehensive and coherent Statute.
干细胞在研究中的应用引发了诸多争议和伦理困境。干细胞的主要来源是人类胚胎，这一来源因伦理、道德和宗教立场而遭到反对。约旦在该地区通过了首个此类法规，旨在规范干细胞在治疗和研究目的方面的使用。该法规采取了一种介于严格限制和适度管控之间的监管方式。然而，该法规在许多条款中更关注干细胞库。在规范干细胞研究活动的许多关键方面被忽视了。这包括但不限于知情同意程序、保护隐私、保密、需要一个负责监管胚胎干细胞（ESC）研究的国家实体以及监测活动的要求。作者建议根据所讨论的缺陷对现行法规进行进一步审查，以制定出更全面、连贯的法规。
